Singapore-based biotechnology firm ImmunoScape has secured fresh funding from existing investor EDBI, the investment arm of the Singapore Economic Development Board (EDB), regulatory filings showed.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
